Clinical Trial Update: Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension [Phase 1]

View source ↗

Summary

An early-phase study (Phase 1) evaluating KK3910 in healthy volunteers and patients with essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• KK3910

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Healthy Volunteers Essential Hypertension | Phase 1 | Status: RECRUITING